Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2012 Apr-Jun;16(2):229-35.
doi: 10.4293/108680812x13427982376266.

Laparoscopic transperitoneal infrarenal para-aortic lymphadenectomy in patients with FIGO stage IB1-II B cervical carcinoma

Dae G Hong  1 , Nae Y Park, Gun O Chong, Young L Cho, Il S Park, Yoon S Lee, Dae Hyung Lee
Affiliations
Comparative Study

Laparoscopic transperitoneal infrarenal para-aortic lymphadenectomy in patients with FIGO stage IB1-II B cervical carcinoma

Dae G Hong et al. JSLS. 2012 Apr-Jun.

Abstract

Background and objectives: This study aimed to evaluate the safety, feasibility, and clinical outcomes of laparoscopic transperitoneal infrarenal para-aortic lymphadenectomy in patients with FIGO stage IB1-IIB cervical carcinoma.

Methods: Between August 1999 and April 2009, we performed 59 laparoscopic transperitoneal lymphadenectomies; specifically, 12 procedures were performed up to the level of the left renal vessels, and 47 procedures were performed up to the level of the inferior mesenteric artery. We retrospectively analyzed the pathology reports and clinical data and compared the 2 groups. The data were analyzed with a nonparametric Mann-Whitney test, Kaplan-Meier log-rank test, and Pearson's correlation analysis.

Results: The 2 groups did not significantly differ with respect to histologic type (P = .093), clinical stage (P = .053), tumor size (P = .383), time interval to start adjuvant therapy postoperatively (P = .064), and type of adjuvant therapy (P = .407). The blood loss (P = .131), operative time (P = .200), mean hospital stay (P = .417), and postoperative self-voiding (P = .306) did not significantly differ between the groups, with the exception of the number of harvested lymph nodes (P = .001). The disease-free survival was better in the group that underwent infrarenal para-aortic lymphadenectomy than the group that did not (P = .017); however, the 2 groups did not differ with respect to overall survival (P = .115).

Conclusion: We suggest that laparoscopic transperitoneal infrarenal lymphadenectomy for cervical cancer is feasible and safe. The rate of positive lymph nodes in infrarenal lymphadenectomy is very rare in patients with locally advanced cervical carcinoma. Infrarenal lymphadenectomy in patients with cervical cancer did not provide additional survival benefits in this study.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Para-aortic and pelvic lymphadenectomy. (A: left renal vein, B: vena cava, C: aorta, D: inferior mesenteric artery, E: both common iliac artery, F: right ureter)
Figure 2.
Figure 2.
Cumulative overall survival and disease-free survival in groups that did and did not undergo infrarenal para-aortic lymphadenectomy.
Figure 3.
Figure 3.
Regression analysis of operative on time, blood loss, and number of harvested lymph nodes relative to the increasing number of cases performed.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Bidus MA, Elkas JC. Cervical and vaginal cancer. In: Jonathan S.B., ed. Berek's and Hacker's Gynecologic Oncology. Philadelphia: Lippincott Williams & Wilkins; 2007;1427
    1. National Comprehesive Cancer Network (2012). Cervical Cancer Version 1.2012.Available online: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp
    1. Hacker NF, Wain GV, Nicklin JL. Resection of bulky positive lymph nodes in patients with cervical cancer. Int J Gynecol Cancer. 1995;5:520–256 - PubMed
    1. Landoni F, Maneo A, Colombo A, et al. Randomized study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 1997;350:535–540 - PubMed
    1. Querleu D. Laparoscopic paraaortic node sampling in gynecologic oncology: a preliminary experience. Gynecol Oncol. 1993;49:24–29 - PubMed

Publication types